Levothyroxine Sodium Tablets, USP, 200 mcg (0.2 mg), packaged in a) 90-count bottles (NDC 16729-457-15) and b) 1000-cou
ACCORD HEALTHCARE, INC.
Subpotent Drug
12 recalls found for ACCORD HEALTHCARE, INC. — August 2026.
The recalls listed below are active notices associated with ACCORD HEALTHCARE, INC. in the FDA, NHTSA, USDA, and CPSC databases. None of the current recalls are classified as urgent. Check the specific lot numbers, model numbers, or production date codes in each notice carefully — a recall typically covers specific production runs, not everything a manufacturer sells.
A manufacturer appearing in the recall database does not indicate an ongoing safety failure. High-volume companies with large product lines naturally appear more frequently. What matters is whether your specific product — identified by lot number, model number, or date code — is included in a recall notice.
Browse all medication recalls →ACCORD HEALTHCARE, INC.
Subpotent Drug
ACCORD HEALTHCARE, INC.
Subpotent Drug
ACCORD HEALTHCARE, INC.
Subpotent Drug
ACCORD HEALTHCARE, INC.
Subpotent Drug
ACCORD HEALTHCARE, INC.
Subpotent Drug
ACCORD HEALTHCARE, INC.
Subpotent Drug
ACCORD HEALTHCARE, INC.
Subpotent Drug
ACCORD HEALTHCARE, INC.
Subpotent Drug
ACCORD HEALTHCARE, INC.
Subpotent Drug
ACCORD HEALTHCARE, INC.
Subpotent Drug
ACCORD HEALTHCARE, INC.
Subpotent Drug
ACCORD HEALTHCARE, INC.
Subpotent Drug